All News

CDER recently announced that it will elevate the Office of Compliance to a Super Office to continue to ensure the safety, quality, and integrity of drugs in America, according to a memo from CDER Director Janet Woodcock.

Several lots of azithromycin, Quinapril, and other drugs were stolen in mid-May from Pfizer and its Greenstone subsidiary when a company truck was en route to a CVS store.

Integrated television-based technology can help hospitals meet the patient-centeredness requirements of federal reform initiatives, stated a recent white paper released by LodgeNet Healthcare, a provider of media and connectivity solutions for hospitals.

Early commencement of oral antiretroviral therapy by men and women infected with HIV substantially reduced the risk that they would transmit the virus to their uninfected sexual partners, according to findings from a large multinational clinical study conducted by the HIV Prevention Trials Network.

Vardenafil HCI (Staxyn, GlaxoSmithKline, Merck, and Bayer), an orally disintegrating tablet indicated for the treatment of erectile dysfunction in men, is now available in U.S. pharmacies.

The National Community Pharmacists Association Conference taking place May 23 to May 25 in Washington, D.C., at the Hyatt Regency on Capitol Hill is focusing on how the expert medication counseling and new, nontraditional services provided by local pharmacists can help reduce costs and improve patient outcomes.

Proton pump inhibitors are associated with a 29% increased risk of fracture, including a 31% increased risk of hip fracture and a 54% increased risk of vertebral fracture, according to a study published in the May/June 2011 issue of Annals of Family Medicine.

There is no safe therapeutic window of time for using NSAIDs in patients with prior myocardial infarction. Even short-term treatment with most NSAIDs appears associated with increased risk of death and recurrent MI, reported a study published in Circulation.